Clinical Trials in New Brighton, Minnesota
13 recruiting
Showing 1–13 of 13 trials
Recruiting
Phase 3
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
Plaque Psoriasis
Bristol-Myers Squibb3,040 enrolled357 locationsNCT07116967
Recruiting
Phase 2
Dose Ranging Study of ORKA-002 in Patients With Moderate-to-Severe Plaque Psoriasis
Plaque Psoriasis
Oruka Therapeutics, Inc.160 enrolled27 locationsNCT07474792
Recruiting
Phase 3
Study of Reformulated Levulan Kerastick Plus PDT for Actinic Keratosis on Upper Extremities
Actinic Keratosis
Sun Pharmaceutical Industries, Inc.260 enrolled20 locationsNCT07144852
Recruiting
Phase 3
Study of Reformulated Levulan Kerastick Plus PDT for Actinic Keratosis on Face and Scalp
Actinic Keratosis
Sun Pharmaceutical Industries, Inc.160 enrolled10 locationsNCT07144345
Recruiting
Phase 3
A Study to Investigate Safety and Efficacy of Tapinarof Cream, 1% in Participants Ages 3 Months to < 24 Months With Atopic Dermatitis
Atopic Dermatitis
Organon and Co180 enrolled48 locationsNCT07265479
Recruiting
Phase 3
Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Hidradenitis Suppurativa (TRuE-HS1)
Hidradenitis Suppurativa
Incyte Corporation550 enrolled101 locationsNCT06959225
Recruiting
Phase 3
A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata
Alopecia Areata
AbbVie1,500 enrolled268 locationsNCT06012240
Recruiting
Phase 1Phase 2
Evaluate RLS-1496 Topical Cream for Actinic Keratosis
Actinic Keratosis (AK)
Rubedo Life Sciences, Inc.24 enrolled4 locationsNCT07340697
Recruiting
Phase 3
Safety and Efficacy of VDPHL01 in Females With Androgenetic Alopecia (AGA)
Androgenetic alopecia (AGA)Hair LossAGA+2 more
Veradermics, Inc.552 enrolled71 locationsNCT07146022
Recruiting
Phase 2
Phase 2b Safety and Efficacy Study of CGB-500 Topical Ointment with 0.5% and 1% Tofacitnib for Treatment of Atopic Dermatitis
Atopic Dermatitis (AD)
CAGE Bio Inc.180 enrolled16 locationsNCT06810050
Recruiting
Phase 2
A Trial to Evaluate the Safety and Efficacy of SM-020 Gel 1.0% in Subjects With Seborrheic Keratosis
Seborrheic Keratosis
DermBiont, Inc.60 enrolled4 locationsNCT06108024
Recruiting
Protocol for a Research Sample Repository for Hematopoietic Cell Transplantation, Other Cellular Therapies and Marrow Toxic Injuries
allogeneic stem cell transplantationAutologous Stem Cell TransplantationCellular Therapy+1 more
Center for International Blood and Marrow Transplant Research99,999,999 enrolled1 locationNCT04920474
Recruiting
Phase 3
A Study Evaluating the Safety and Pharmacokinetics of QTORIN Rapamycin 3.9% Anhydrous Gel in the Treatment of Adults With Pachyonychia Congenita
Pachyonychia Congenita
Palvella Therapeutics, Inc.45 enrolled1 locationNCT05643872